ATXA Therapeutics
PrivateLast Round
Crowdfunding
Jan 22, 2024
Est. Valuation
$37.46M
Total Funding Raised
$10.14M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ATXA Therapeutics operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was a Crowdfunding round in January 2024.
ATXA Therapeutics is a clinical-stage pharmaceutical company that develops novel, life-changing treatments for cardiopulmonary diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ATXA Therapeutics Comparables
Compare ATXA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cereno Scientific | 78% | |
| Sumitomo Pharma Co., Ltd. | 71% | |
| Gossamer Bio | 71% |
For institutional investors. Book with your work email.
ATXA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jan 22, 2024 | ||||
| Grant | Oct 21, 2022 | ||||
| Grant | Oct 31, 2018 | ||||
| Seed | Apr 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ATXA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| European Commission | Grant |
| Spark Venture Funding | Crowdfunding |
| Enterprise Ireland | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 64% MoM, from 668 to 1.1K.
- Jun 20, 2026
Monthly visitors increased 35% MoM.
For institutional investors. Book with your work email.
ATXA Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ATXA Therapeutics's valuation, stock price, and market status.
Is ATXA Therapeutics a public or private company?
ATXA Therapeutics is a private company.
What is the current stock price of ATXA Therapeutics?
ATXA Therapeutics is a private company, so its shares have no public market price. Caplight tracks ATXA Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ATXA Therapeutics worth (valuation)?
ATXA Therapeutics's valuation is estimated at $37.5M based on funding round data.
Can I buy ATXA Therapeutics stock?
ATXA Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ATXA Therapeutics's last funding round?
ATXA Therapeutics's most recent funding round was Crowdfunding on January 22, 2024.
Who are the main investors in ATXA Therapeutics?
Key investors in ATXA Therapeutics include European Innovation Council Fund, European Commission, Spark Venture Funding, Enterprise Ireland.
Will ATXA Therapeutics IPO soon?
No public IPO plans have been announced for ATXA Therapeutics.
How can I track ATXA Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in ATXA Therapeutics's shares on secondary markets.